Imricor’s Chair and CEO, Steve Wedan, said, “After last week’s announcement regarding Ethics Committee approval at the CHUV in Lausanne, we are very excited to announce that the Ethics Committee at ICPS has followed so quickly."
Imricor says Paris-based CV institute grants ethics approval for VISABL-AFL trial
March 11, 2024 Australian BiotechLatest Video
New Stories
-
NZ Government appoints former Deputy PM new chair of Pharmac
April 29, 2024 - - Latest News -
The listing will 'benefit thousands of Australian women', says Mark Butler
April 29, 2024 - - Latest News -
'An important first step to achieving reimbursed access for eligible patients in Australia'
April 28, 2024 - - Latest News -
The 'Week in Review' Podcast - 26 April
April 28, 2024 - - Podcast -
New research shows adult vaccination programs deliver major return on investment
April 26, 2024 - - Latest News -
Productivity Commission research backs the benefit of faster access to medicines
April 26, 2024 - - Latest News -
Let's make decisions based on credible information and not guesswork
April 24, 2024 - - Latest News